These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1262859)

  • 1. Treatment of chronic post-traumatic organic brain syndrome with dextroamphetamine: first reported case.
    Lipper S; Tuchman MM
    J Nerv Ment Dis; 1976 May; 162(5):366-71. PubMed ID: 1262859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of psychoactive drugs in the outpatient treatment of psychiatric disorders of children.
    Kraft IA
    Am J Psychiatry; 1968 Apr; 124(10):1401-7. PubMed ID: 5643658
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children.
    Greenberg LM; Deem MA; McMahon S
    Am J Psychiatry; 1972 Nov; 129(5):532-9. PubMed ID: 4562464
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive therapeutic response to lithium in hypomania secondary to organic brain syndrome.
    Rosenbaum AH; Barry MJ
    Am J Psychiatry; 1975 Oct; 132(10):1072-3. PubMed ID: 1166880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case study: antimanic effectiveness of dextroamphetamine in a brain-injured adolescent.
    Max JE; Richards L; Hamdan-Allen G
    J Am Acad Child Adolesc Psychiatry; 1995 Apr; 34(4):472-6. PubMed ID: 7751261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug comparison in hyperactive children.
    Safer DJ; Allen RP
    Am J Psychiatry; 1973 Aug; 130(8):939-40. PubMed ID: 4577472
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.
    Goldberg TE; Bigelow LB; Weinberger DR; Daniel DG; Kleinman JE
    Am J Psychiatry; 1991 Jan; 148(1):78-84. PubMed ID: 1984711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
    Childress AC; Brams M; Cutler AJ; Kollins SH; Northcutt J; Padilla A; Turnbow JM
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):402-14. PubMed ID: 25692608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 11. Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating.
    Arnold LE; Huestis RD; Smeltzer DJ; Scheib J; Wemmer D; Colner G
    Arch Gen Psychiatry; 1976 Mar; 33(3):292-301. PubMed ID: 769721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of d-amphetamine and chlorpromazine in rats.
    Lu TC; Claghorn JL; Schoolar JC
    Eur J Pharmacol; 1973 Jan; 21(1):61-5. PubMed ID: 4709206
    [No Abstract]   [Full Text] [Related]  

  • 13. Dextroamphetamine with morphine for the treatment of postoperative pain.
    Forrest WH; Brown BW; Brown CR; Defalque R; Gold M; Gordon HE; James KE; Katz J; Mahler DL; Schroff P; Teutsch G
    N Engl J Med; 1977 Mar; 296(13):712-5. PubMed ID: 320478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-traumatic deficit syndromes].
    Assal G
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):17-24. PubMed ID: 2413535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic brain injury as an etiology of organic affective syndrome.
    Zeff K; Chung R
    Mil Med; 1987 Oct; 152(10):529-30. PubMed ID: 3120050
    [No Abstract]   [Full Text] [Related]  

  • 16. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.
    Rapoport JL; Buchsbaum MS; Zahn TP; Weingartner H; Ludlow C; Mikkelsen EJ
    Science; 1978 Feb; 199(4328):560-3. PubMed ID: 341313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Findings in treatment with cerebrolysin].
    Medvecký J; Jassová Z; Medvecká E
    Cesk Psychiatr; 1982 Oct; 78(5):308-11. PubMed ID: 7172295
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The return of memory and personal meaning. Treatment and theoretical considerations in a case of viral encephalitis.
    Wagonfeld S; Dashef SS
    J Am Acad Child Psychiatry; 1973 Apr; 12(2):314-32. PubMed ID: 4702094
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE; Christopher J; Huestis R; Smeltzer DJ
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.